Luigi Gianolli

Istituti di Ricovero e Cura a Carattere Scientifico

Papers

1

Total Citations

94

H-Index

1

About

Luigi Gianolli is a leading figure in the surgical management of prostate cancer, with a primary focus on advancing precision oncology through radioguided surgery. His most impactful work centers on the intraoperative detection of lymph node metastases using Prostate-Specific Membrane Antigen (PSMA) technology. In a landmark prospective Phase 2 study, Gianolli demonstrated the feasibility and accuracy of PSMA radioguided surgery (RGS) during robot-assisted radical prostatectomy and extended pelvic lymph node dissection. This work, cited nearly 100 times, provides compelling evidence that RGS can identify cancerous nodes that might otherwise be missed, potentially improving staging accuracy and guiding adjuvant therapy decisions. By integrating molecular imaging directly into the surgical field, Gianolli is helping to bridge the gap between diagnostic imaging and therapeutic intervention. His research represents a significant step toward more personalized, targeted treatment for primary prostate cancer patients, offering the promise of reducing unnecessary morbidity while ensuring complete oncologic resection.

Research Focus

Key Achievements

1
H-Index
1
Papers
94
Total Citations
94
Avg Citations/Paper
🏆 Most Cited Paper
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study
94 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Istituti di Ricovero e Cura a Carattere Scientifico

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago